1-1 of 1
Charlene Fallan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A first-in-class oral clinical candidate targeting MLLT1 and 3 degradation for the treatment of advanced AML and ALL including menin inhibitor resistant / refractory disease

Free
Iain Simpson, Gilbert Ansa, Graham Craggs, Charlene Fallan, Gillian Farnie, Matthew Fawkes, Fenella Gross, Joe Harman, Sarah Major, Alison Maloney, Thomas Milne, John Pollard
Journal: Blood
Blood (2025) 146 (Supplement 1): 754.
https://doi.org/10.1182/blood-2025-754
Published: 2025